Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
- PMID: 8759090
- DOI: 10.1161/01.cir.94.3.467
Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
Abstract
Background: A subgroup of patients with hypertrophic obstructive cardiomyopathy remain severely symptomatic despite optimal medical therapy. Septal myectomy reduces or eliminates left ventricular outflow obstruction and produces marked symptomatic improvement. With the recent advent of alternative methods for treatment of this disorder, such as dual-chamber pacing, it is necessary to establish the risks and benefits of septal myectomy in the modern surgical era.
Methods and results: The clinical, ECG, echocardiographic, cardiac catheterization, and surgical data were analyzed for 65 patients 20 to 70 years old with hypertrophic obstructive cardiomyopathy who had surgical treatment between 1986 and 1992. Specific symptoms and overall functional status were evaluated before surgery and at the end of the first postoperative year. Subsequent long-term clinical postoperative follow-up was also obtained. The extent of postoperative improvement was measured by the presence and severity of persistent symptoms, overall New York Heart Association (NYHA) functional class, and patients' self-perceptions of overall improvement. Of the patients, 95% were in NYHA functional class III or IV before surgery: 95% had dyspnea, 62% had angina, 63% had near-syncope, and 23% had syncope. The overall early mortality rate was 4.6%; there was no mortality among the 45 patients who underwent isolated septal myectomy. At the 1-year postoperative evaluation, 89% of survivors were in NYHA functional class I or II, and 47% believed that they had 100% improvement. Significant improvement (as defined) was seen in 67% of patients with dyspnea, 90% with angina, 86% with near-syncope, and 100% with syncope. The 5-year survival rate was 92%.
Conclusions: The results of the present study reaffirm the efficacy of surgical treatment of hypertrophic obstructive cardiomyopathy in patients who are severely symptomatic despite optimal medical therapy and serve as a useful reference by which the surgical approach can be compared with new and potentially promising treatment alternatives.
Similar articles
-
Hypertrophic obstructive cardiomyopathy: preoperative echocardiographic predictors of outcome after septal myectomy.J Am Coll Cardiol. 1996 May;27(6):1491-6. doi: 10.1016/0735-1097(96)00038-1. J Am Coll Cardiol. 1996. PMID: 8626964
-
Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.J Thorac Cardiovasc Surg. 2012 Feb;143(2):303-9. doi: 10.1016/j.jtcvs.2011.10.059. Epub 2011 Dec 10. J Thorac Cardiovasc Surg. 2012. PMID: 22154797
-
Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.Circulation. 1994 Dec;90(6):2731-42. doi: 10.1161/01.cir.90.6.2731. Circulation. 1994. PMID: 7994815
-
Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation.Circ Res. 2017 Sep 15;121(7):771-783. doi: 10.1161/CIRCRESAHA.116.309348. Circ Res. 2017. PMID: 28912182 Review.
-
[Non-pharmacological treatment of hypertrophic obstructive cardiomyopathy guided by echocardiography].G Ital Cardiol (Rome). 2006 Mar;7(3):192-205. G Ital Cardiol (Rome). 2006. PMID: 16572985 Review. Italian.
Cited by
-
Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy.Clin Cardiol. 2009 Jul;32(7):397-402. doi: 10.1002/clc.20594. Clin Cardiol. 2009. PMID: 19609895 Free PMC article.
-
Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.Curr Cardiol Rev. 2016;12(4):285-296. doi: 10.2174/1573403x11666150107160344. Curr Cardiol Rev. 2016. PMID: 25563291 Free PMC article. Review.
-
Management of hypertrophic cardiomyopathy in children.Paediatr Drugs. 2003;5(10):663-72. doi: 10.2165/00148581-200305100-00002. Paediatr Drugs. 2003. PMID: 14510624 Review.
-
Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective.Heart Vessels. 2009 Jan;24(1):27-31. doi: 10.1007/s00380-008-1083-4. Epub 2009 Jan 23. Heart Vessels. 2009. PMID: 19165565
-
Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience.Ann Cardiothorac Surg. 2017 Jul;6(4):329-336. doi: 10.21037/acs.2017.07.03. Ann Cardiothorac Surg. 2017. PMID: 28944173 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources